Form 4: Astronics Corp Executive James Mulato Reports Changes in Beneficial Ownership
SEC Form 4 Filing
James Mulato, President of Astronics Test Systems, reports acquisition and disposal of Astronics Corp stock and stock options, including shares awarded as a bonus and shares withheld for tax obligations.
Summary
- James Mulato, President of Astronics Test Systems, filed a Form 4 detailing changes in his beneficial ownership of Astronics Corp stock.
- The reported transactions include the acquisition of common stock as part of a bonus plan payout and the company's 401(k) contribution.
- Shares were also withheld to cover applicable withholding taxes upon the grant of the stock bonus award.
- Mulato also reports holdings of various stock options and restricted stock units (RSUs) with different vesting schedules and performance-based vesting conditions tied to Astronics Corp.'s average annual adjusted EBITDA.
- The RSUs vest over three years, with the number of units vesting dependent on the company's EBITDA performance during specific periods.
- Some RSUs have vesting percentages that can range from 50% to 150% based on performance.
Sentiment
Score: 6
Explanation: The document primarily reflects routine executive compensation adjustments. The sentiment is neutral, with a slight positive leaning due to the stock bonus awards, indicating confidence in the company's performance.
Positives
- The acquisition of shares as part of a bonus plan payout suggests confidence in the company's future performance.
- The company's 401(k) contribution to Mulato's account further aligns his interests with the company's success.
Negatives
- The withholding of shares for tax obligations reduces the immediate benefit of the stock bonus awards.
Risks
- The vesting of a significant portion of Mulato's restricted stock units is contingent upon Astronics Corp.'s average annual adjusted EBITDA performance, which introduces uncertainty.
- Fluctuations in the company's stock price could impact the value of Mulato's stock options and RSUs.
Future Outlook
The vesting of restricted stock units is tied to the company's future EBITDA performance, incentivizing the reporting person to contribute to the company's financial success.
Industry Context
Executive compensation packages often include stock options and restricted stock units to align management's interests with those of shareholders. The vesting conditions tied to EBITDA performance are a common practice to incentivize profitability and growth.
Comparison to Industry Standards
- Stock options with multi-year vesting schedules are standard practice in executive compensation, similar to companies like Boeing and Lockheed Martin.
- Using EBITDA as a performance metric for vesting RSUs is also common, aligning with industry practices seen at companies such as TransDigm Group.
- The vesting percentages of 50%-150% based on performance are within the typical range for performance-based equity awards.
Stakeholder Impact
- Shareholders may view the stock bonus awards as a positive sign, aligning executive interests with company performance.
- Employees may be motivated by the company's performance-based compensation structure.
Key Dates
| Date | Description |
|---|---|
| 03/31/2015 | Grant date of some stock options with an exercise price of $34.75 and an expiration date of 03/31/2024. |
| 12/11/2015 | Grant date of some stock options with an exercise price of $30.83 and an expiration date of 12/11/2024. |
| 12/03/2016 | Grant date of some stock options with an exercise price of $27.72 and an expiration date of 12/03/2025. |
| 12/14/2017 | Grant date of some stock options with an exercise price of $31.76 and an expiration date of 12/14/2026. |
| 12/12/2018 | Grant date of some stock options with an exercise price of $35.61 and an expiration date of 12/12/2027. |
| 12/13/2019 | Grant date of some stock options with an exercise price of $31.57 and an expiration date of 12/13/2028. |
| 12/09/2020 | Grant date of some stock options with an exercise price of $30.04 and an expiration date of 12/09/2029. |
| January1, 2021December 31, 2023 | Period for determining Astronics Corp.'s average annual adjusted EBITDA for vesting of some restricted stock units. |
| 01/22/2022 | Grant date of some stock options with an exercise price of $14.45 and an expiration date of 01/22/2031. |
| January1, 2022December 31, 2024 | Period for determining Astronics Corp.'s average annual adjusted EBITDA for vesting of some restricted stock units. |
| 12/09/2022 | Grant date of some stock options with an exercise price of $11.13 and an expiration date of 12/09/2031. |
| January 1, 2023December 31, 2025 | Period for determining Astronics Corp.'s average annual adjusted EBITDA for vesting of some restricted stock units. |
| 12/16/2023 | Grant date of some stock options with an exercise price of $9.74 and an expiration date of 12/16/2032. |
| 03/01/2024 | Date of the earliest transaction reported in the Form 4 filing. |
| January 1, 2024December 31, 2026 | Period for determining Astronics Corp.'s average annual adjusted EBITDA for vesting of some restricted stock units. |
| 12/07/2024 | Grant date of some stock options with an exercise price of $15.15 and an expiration date of 12/07/2033. |
| 02/24/2025 | Potential vesting date for some restricted stock units, dependent on Astronics Corp.'s average annual adjusted EBITDA. |
| 02/23/2026 | Potential vesting date for some restricted stock units, dependent on Astronics Corp.'s average annual adjusted EBITDA. |
| 02/22/2027 | Potential vesting date for some restricted stock units, dependent on Astronics Corp.'s average annual adjusted EBITDA. |
| 03/05/2024 | Date of the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.